184 related articles for article (PubMed ID: 22778098)
21. Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2.
Friis LM; Keelan M; Taylor DE
Infect Immun; 2009 Apr; 77(4):1553-60. PubMed ID: 19139198
[TBL] [Abstract][Full Text] [Related]
22. Distribution of genes related to Type 6 secretion system and lipooligosaccharide that induced ganglioside mimicry among
Serichantalergs O; Wassanarungroj P; Khemnu N; Poly F; Guerry P; Bodhidatta L; Crawford J; Swierczewski B
Gut Pathog; 2020; 12():18. PubMed ID: 32308743
[TBL] [Abstract][Full Text] [Related]
23. Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis.
Mortensen NP; Kuijf ML; Ang CW; Schiellerup P; Krogfelt KA; Jacobs BC; van Belkum A; Endtz HP; Bergman MP
Microbes Infect; 2009 Oct; 11(12):988-94. PubMed ID: 19631279
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor inhibits Campylobacter jejuni-induced claudin-4 disruption, loss of epithelial barrier function, and Escherichia coli translocation.
Lamb-Rosteski JM; Kalischuk LD; Inglis GD; Buret AG
Infect Immun; 2008 Aug; 76(8):3390-8. PubMed ID: 18490463
[TBL] [Abstract][Full Text] [Related]
25. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner.
Bax M; Kuijf ML; Heikema AP; van Rijs W; Bruijns SC; García-Vallejo JJ; Crocker PR; Jacobs BC; van Vliet SJ; van Kooyk Y
Infect Immun; 2011 Jul; 79(7):2681-9. PubMed ID: 21502591
[TBL] [Abstract][Full Text] [Related]
26. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
27. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.
Guerry P; Szymanski CM; Prendergast MM; Hickey TE; Ewing CP; Pattarini DL; Moran AP
Infect Immun; 2002 Feb; 70(2):787-93. PubMed ID: 11796612
[TBL] [Abstract][Full Text] [Related]
28. Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells.
Elmi A; Watson E; Sandu P; Gundogdu O; Mills DC; Inglis NF; Manson E; Imrie L; Bajaj-Elliott M; Wren BW; Smith DG; Dorrell N
Infect Immun; 2012 Dec; 80(12):4089-98. PubMed ID: 22966047
[TBL] [Abstract][Full Text] [Related]
29. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
Shu XM; Cai FC; Zhang XP
Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
[TBL] [Abstract][Full Text] [Related]
30. Lipooligosaccharide locus classes and putative virulence genes among chicken and human Campylobacter jejuni isolates.
Ellström P; Hansson I; Nilsson A; Rautelin H; Olsson Engvall E
BMC Microbiol; 2016 Nov; 16(1):116. PubMed ID: 27871232
[TBL] [Abstract][Full Text] [Related]
31. Attachment, invasion, and translocation of Campylobacter jejuni in pig small-intestinal epithelial cells.
Pogacar MS; Klancnik A; Mozina SS; Cencic A
Foodborne Pathog Dis; 2010 May; 7(5):589-95. PubMed ID: 20039793
[TBL] [Abstract][Full Text] [Related]
32. Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation.
Stephenson HN; John CM; Naz N; Gundogdu O; Dorrell N; Wren BW; Jarvis GA; Bajaj-Elliott M
J Biol Chem; 2013 Jul; 288(27):19661-72. PubMed ID: 23629657
[TBL] [Abstract][Full Text] [Related]
33. Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-mhz (1)h and (13)c NMR analysis.
Gilbert M; Brisson JR; Karwaski MF; Michniewicz J; Cunningham AM; Wu Y; Young NM; Wakarchuk WW
J Biol Chem; 2000 Feb; 275(6):3896-906. PubMed ID: 10660542
[TBL] [Abstract][Full Text] [Related]
34. Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni.
Linton D; Gilbert M; Hitchen PG; Dell A; Morris HR; Wakarchuk WW; Gregson NA; Wren BW
Mol Microbiol; 2000 Aug; 37(3):501-14. PubMed ID: 10931344
[TBL] [Abstract][Full Text] [Related]
35. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
Godschalk PC; Heikema AP; Gilbert M; Komagamine T; Ang CW; Glerum J; Brochu D; Li J; Yuki N; Jacobs BC; van Belkum A; Endtz HP
J Clin Invest; 2004 Dec; 114(11):1659-65. PubMed ID: 15578098
[TBL] [Abstract][Full Text] [Related]
36. Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells.
Beltinger J; del Buono J; Skelly MM; Thornley J; Spiller RC; Stack WA; Hawkey CJ
World J Gastroenterol; 2008 Dec; 14(48):7345-52. PubMed ID: 19109868
[TBL] [Abstract][Full Text] [Related]
37. Mass spectrometric analysis of intact lipooligosaccharide: direct evidence for O-acetylated sialic acids and discovery of O-linked glycine expressed by Campylobacter jejuni.
Dzieciatkowska M; Brochu D; van Belkum A; Heikema AP; Yuki N; Houliston RS; Richards JC; Gilbert M; Li J
Biochemistry; 2007 Dec; 46(50):14704-14. PubMed ID: 18034462
[TBL] [Abstract][Full Text] [Related]
38. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.
Poly F; Read TD; Chen YH; Monteiro MA; Serichantalergs O; Pootong P; Bodhidatta L; Mason CJ; Rockabrand D; Baqar S; Porter CK; Tribble D; Darsley M; Guerry P
Infect Immun; 2008 Dec; 76(12):5655-67. PubMed ID: 18809665
[TBL] [Abstract][Full Text] [Related]
39. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide.
Linton D; Karlyshev AV; Hitchen PG; Morris HR; Dell A; Gregson NA; Wren BW
Mol Microbiol; 2000 Mar; 35(5):1120-34. PubMed ID: 10712693
[TBL] [Abstract][Full Text] [Related]
40. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.
O'Hara JR; Feener TD; Fischer CD; Buret AG
Infect Immun; 2012 Apr; 80(4):1563-71. PubMed ID: 22311925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
